🇺🇸 FDA
Pipeline program

TDF

GS-US-174-0149

Approved small_molecule completed

Quick answer

TDF for Chronic Hepatitis B is a Approved program (small_molecule) at Gilead Sciences Ireland UC with 1 ClinicalTrials.gov record(s).

Program details

Company
Gilead Sciences Ireland UC
Indication
Chronic Hepatitis B
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials